The review — which didn't consist of tirzepatide as part of the Assessment — was framed like a counterpoint to a different examine that found that GLP-1 agonists increased the risk for pancreatitis.BOSTON — Clinicians at inside drugs and endocrinology conferences lately introduced circumstance reviews describing pancreatitis in people using t